Expert opinions

In conjunction with the legislative work regarding the field of reproductive medicine expert opinions on various aspects have been commissioned.

External opinions that were commissioned in conjunction with legislative efforts on the Reproductive Medicine Act are listed below.

Listed first, the batch of expert opinions on various aspects of pre-implantation genetic diagnosis (PGD), followed by opinions related to other aspects of the reproductive medicine regulatory area.

(Not all of these documents are available in English)

Documents

Pre-implantation genetic diagnosis (PGD)

Societal implications of pre-implantation genetic diagnosis. An overview of the results of relevant empirical studies (PDF, 634 kB, 20.12.2016)Sociological review by Prof. Thomas Lemke and Jonas Rüppel, Dipl.-Soz., Dipl.-Psych., Goethe University, Frankfurt am Main, November 2016 (German only)

Pre-implantation genetic diagnosis and eugenics, part one (PDF, 629 kB, 01.01.2013)Review by Prof. Kurt Seelmann and Dr Daniela Demko PD, LL.M. Eur., Universities of Lucerne and Basel (German only)

Pre-implantation genetic diagnosis and eugenics, part two (PDF, 158 kB, 01.02.2014)Review by Prof. Kurt Seelmann and Dr Daniela Demko PD, LL.M. Eur., Universities of Lucerne and Basel (German only)

Regulating PGD: an ethical perspective (PDF, 255 kB, 31.01.2013)Ethical review by Prof. Peter Schaber, Center for Ethics, University of Zurich (German only)

Should pre-implantation genetic diagnosis (PGD) be permissible under the same conditions as prenatal diagnosis? (PDF, 32 kB, 31.10.2012)ethical review by Markus Zimmermann-Acklin, Th.D., PD, University of Fribourg (German only)

Pre-implantation genetic diagnosis I (PDF, 275 kB, 01.12.2005)NCE opinion no. 10/2005 of the National Advisory Commission on Biomedical Ethics (German only)

Pre-implantation genetic diagnosis II – specific issues associated with statutory regulation and HLA typing (PDF, 181 kB, 30.11.2007)NCE opinion no. 14/2007 of the National Advisory Commission on Biomedical Ethics (German only)


Other aspects of the reproductive medicine regulatory area

Access to reproductive medicine for all? (PDF, 802 kB, 30.05.2018)Review by emeritus Prof. Kurt Seelmann, Basel (German only)

Medically assisted reproduction: Ethical considerations and recommendations for the future (PDF, 282 kB, 30.11.2013)Opinion No. 22/2013 of the Swiss National Advisory Commission on Biomedical Ethics

Review of child welfare and the RMA (PDF, 2 MB, 21.01.2013)Sociological review by Dr Heidi Simoni, Marie Meierhofer Institute for Children, Zurich (German only)

Egg donation in Switzerland, lex lata and lex ferenda (PDF, 556 kB, 17.06.2014)Legal review by Prof. Andrea Büchler, University of Zurich (German only)

Egg Donation and IVF with Donated Eggs: Lessons to be Learned from other Countries (PDF, 1 MB, 05.09.2014)Sociological review by Nolwenn Bühler, Lic. phil., University of Zurich

Maximum age for assisted reproductive techniques in women (PDF, 108 kB, 10.09.2014)Brief medical review by Dr Dorothea Wunder, MD, PD, Lausanne University Hospital (CHUV) (German only)

Legislation

Reproductive medicine legislation

The Federal Act of 18 December 1998 on Medically Assisted Reproduction lays down the conditions under which the methods of medically assisted reproduction may be used.

Further information

Reproductive medicine

In Switzerland medically assisted reproduction treatment can be sought in 25 to 30 fertility centres. The legal framework regulating access to these treatments is stipulated in the Reproductive Medicine Act.

Last modification 25.10.2019

Top of page

Contact

Federal Office of Public Health FOPH
Division of Biomedicine
Biosafety, Human Genetics and Reproductive Medicine Section
Schwarzenburgstrasse 157
3003 Berne
Switzerland
Tel. +41 58 463 51 54
E-mail

Print contact

https://www.bag.admin.ch/content/bag/en/home/medizin-und-forschung/fortpflanzungsmedizin/stellungnahmen-gutachten.html